These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30144894)

  • 21. Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial.
    Bruzzese E; Raia V; Ruberto E; Scotto R; Giannattasio A; Bruzzese D; Cavicchi MC; Francalanci M; Colombo C; Faelli N; Daccò V; Magazzù G; Costa S; Lucidi V; Majo F; Guarino A
    J Cyst Fibros; 2018 May; 17(3):375-382. PubMed ID: 29128317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial.
    Palacios T; Vitetta L; Coulson S; Madigan CD; Denyer GS; Caterson ID
    Trials; 2017 Jan; 18(1):7. PubMed ID: 28069054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
    Giannetti E; Maglione M; Alessandrella A; Strisciuglio C; De Giovanni D; Campanozzi A; Miele E; Staiano A
    J Clin Gastroenterol; 2017 Jan; 51(1):e5-e10. PubMed ID: 27306945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of a probiotic cocktail containing
    Lennon S; Lackie T; Miltko A; Kearns ZC; Paquette MR; Bloomer RJ; Wang A; van der Merwe M
    Appl Physiol Nutr Metab; 2024 Jul; 49(7):890-903. PubMed ID: 38427981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis.
    Lisowska A; Madry E; Pogorzelski A; Szydłowski J; Radzikowski A; Walkowiak J
    Scand J Clin Lab Invest; 2010 Sep; 70(5):322-6. PubMed ID: 20560844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial.
    Bruzzese E; Callegari ML; Raia V; Viscovo S; Scotto R; Ferrari S; Morelli L; Buccigrossi V; Lo Vecchio A; Ruberto E; Guarino A
    PLoS One; 2014; 9(2):e87796. PubMed ID: 24586292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of probiotic administration on metabolomics and glucose metabolism in CF patients.
    Gur M; Zuckerman-Levin N; Masarweh K; Hanna M; Laghi L; Marazzato M; Levanon S; Hakim F; Bar-Yoseph R; Wilschanski M; Bentur L
    Pediatr Pulmonol; 2022 Oct; 57(10):2335-2343. PubMed ID: 35676769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study.
    Montalto M; Gallo A; Curigliano V; D'Onofrio F; Santoro L; Covino M; Dalvai S; Gasbarrini A; Gasbarrini G
    Aliment Pharmacol Ther; 2010 Jul; 32(2):209-14. PubMed ID: 20384610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.
    Kanhere M; He J; Chassaing B; Ziegler TR; Alvarez JA; Ivie EA; Hao L; Hanfelt J; Gewirtz AT; Tangpricha V
    J Clin Endocrinol Metab; 2018 Feb; 103(2):564-574. PubMed ID: 29161417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study.
    Yoon JY; Cha JM; Oh JK; Tan PL; Kim SH; Kwak MS; Jeon JW; Shin HP
    Dig Dis Sci; 2018 Oct; 63(10):2754-2764. PubMed ID: 29876777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UCC118 supplementation reduces exercise-induced gastrointestinal permeability and remodels the gut microbiome in healthy humans.
    Axelrod CL; Brennan CJ; Cresci G; Paul D; Hull M; Fealy CE; Kirwan JP
    Physiol Rep; 2019 Nov; 7(22):e14276. PubMed ID: 31758610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of supplemental prebiotics, probiotics and bioactive proteins on the microbiome composition and fecal calprotectin in C57BL6/j mice.
    Li Y; Hintze KJ; Ward RE
    Biochimie; 2021 Jun; 185():43-52. PubMed ID: 33609630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
    J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical effects of probiotics in cystic fibrosis patients: A systematic review.
    Van Biervliet S; Declercq D; Somerset S
    Clin Nutr ESPEN; 2017 Apr; 18():37-43. PubMed ID: 29132736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysbiosis in early sepsis can be modulated by a multispecies probiotic: a randomised controlled pilot trial.
    Stadlbauer V; Horvath A; Komarova I; Schmerboeck B; Feldbacher N; Klymiuk I; Durdevic M; Rainer F; Blesl A; Stiegler P; Leber B
    Benef Microbes; 2019 Apr; 10(3):265-278. PubMed ID: 30694100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal Calprotectin in Cystic Fibrosis and Its Relation to Disease Parameters: A Longitudinal Analysis for 12 Years.
    Ellemunter H; Engelhardt A; Schüller K; Steinkamp G
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):438-442. PubMed ID: 28207476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration.
    Bruzzese E; Raia V; Gaudiello G; Polito G; Buccigrossi V; Formicola V; Guarino A
    Aliment Pharmacol Ther; 2004 Oct; 20(7):813-9. PubMed ID: 15379842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics for Constipation in Parkinson Disease: A Randomized Placebo-Controlled Study.
    Tan AH; Lim SY; Chong KK; A Manap MAA; Hor JW; Lim JL; Low SC; Chong CW; Mahadeva S; Lang AE
    Neurology; 2021 Feb; 96(5):e772-e782. PubMed ID: 33046607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.
    Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H
    Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.